• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一篇关于儿科患者口服剂型开发中口感和吞咽性评估的系统文献综述。

A Systematic Literature Review on the Assessment of Palatability and Swallowability in the Development of Oral Dosage Forms for Pediatric Patients.

作者信息

Squires Liza A, Lombardi Donald P, Sjostedt Philip, Thompson Charles A

机构信息

1 Shire LLC, Wayne, PA, USA.

2 Institute for Pediatric Innovation, Cambridge, MA, USA.

出版信息

Ther Innov Regul Sci. 2013 Sep;47(5):533-541. doi: 10.1177/2168479013500288.

DOI:10.1177/2168479013500288
PMID:30235574
Abstract

BACKGROUND

Palatability and swallowability of oral dosage forms are important considerations in the development of medications for pediatric populations. As a result of recent legislation, the number of pharmaceutical products being developed with formulations for children is increasing. However, there are limited recommendations and published literature regarding appropriate palatability and swallowability assessment scales in pediatric patients.

OBJECTIVE

This systematic literature review aimed to identify and evaluate tools currently utilized to assess palatability and swallowability in clinical trials for pediatric oral dosage forms and identify any potential relationships between palatability and treatment adherence. Literature databases were searched for clinical trials that evaluated palatability of oral dosage forms targeted for pediatric patients. The searches were limited to papers in the English language from January 2008 to March 2013.

RESULTS

A total of 137 citations were identified, with 27 articles included in the final full-text analysis.

CONCLUSIONS

Various limitations to this systematic review exist, primarily focused on the unavailability of published, early phase development data related to palatability. However, based on results of this review, palatability is often assessed in clinical trials of pediatric dosage forms through the utilization of 2 unvalidated, yet widely accepted, visual scales. There is no standard statistical methodology for analyzing the results of these scales or the cross-comparison of results across studies. Limited evidence regarding a correlation between palatability and treatment adherence in pediatric patients was identified.

摘要

背景

口服剂型的适口性和吞咽性是儿科用药研发中的重要考量因素。由于近期的法规要求,针对儿童剂型开发的药品数量不断增加。然而,关于儿科患者适口性和吞咽性评估量表的推荐和已发表文献有限。

目的

本系统文献综述旨在识别和评估目前在儿科口服剂型临床试验中用于评估适口性和吞咽性的工具,并确定适口性与治疗依从性之间的潜在关系。检索文献数据库以查找评估儿科患者口服剂型适口性的临床试验。检索限于2008年1月至2013年3月的英文论文。

结果

共识别出137篇文献,最终全文分析纳入27篇文章。

结论

本系统综述存在各种局限性,主要集中在缺乏已发表的与适口性相关的早期研发数据。然而,基于本综述结果,在儿科剂型临床试验中,适口性通常通过使用2种未经验证但被广泛接受的视觉量表进行评估。对于分析这些量表的结果或跨研究结果的交叉比较,没有标准的统计方法。关于儿科患者适口性与治疗依从性之间相关性的证据有限。

相似文献

1
A Systematic Literature Review on the Assessment of Palatability and Swallowability in the Development of Oral Dosage Forms for Pediatric Patients.一篇关于儿科患者口服剂型开发中口感和吞咽性评估的系统文献综述。
Ther Innov Regul Sci. 2013 Sep;47(5):533-541. doi: 10.1177/2168479013500288.
2
Industry Survey on Current Practices in the Assessment of Palatability and Swallowability in the Development of Pediatric Oral Dosage Forms.儿科口服剂型开发中口感和吞咽性评估现行做法的行业调查。
Ther Innov Regul Sci. 2013 Sep;47(5):542-549. doi: 10.1177/2168479013500287.
3
Best Practice Recommendations Regarding the Assessment of Palatability and Swallowability in the Development of Oral Dosage Forms for Pediatric Patients.关于儿科患者口服剂型开发中适口性和吞咽性评估的最佳实践建议。
Ther Innov Regul Sci. 2015 Sep;49(5):647-658. doi: 10.1177/2168479015573585.
4
Assessment of swallowability and palatability of oral dosage forms in children: Report from an M-CERSI pediatric formulation workshop.评估儿童口服剂型的可吞咽性和口感:来自 M-CERSI 儿科制剂研讨会的报告。
Int J Pharm. 2018 Feb 5;536(2):570-581. doi: 10.1016/j.ijpharm.2017.08.088. Epub 2017 Aug 24.
5
Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping Review.患者对固体口服剂型药品属性的可接受性和偏好:一项范围综述
Patient Prefer Adherence. 2024 Jun 21;18:1281-1297. doi: 10.2147/PPA.S443213. eCollection 2024.
6
Young patients' involvement in a composite endpoint method development on acceptability for paediatric oral dosage forms.年轻患者参与儿科口服剂型可接受性的复合终点方法开发。
Res Involv Engagem. 2023 Nov 29;9(1):108. doi: 10.1186/s40900-023-00520-8.
7
Does the Formulation of Oral Solid Dosage Forms Affect Acceptance and Adherence in Older Patients? A Mixed Methods Systematic Review.口服固体制剂的配方是否会影响老年患者的接受度和依从性?一项混合方法系统评价。
J Am Med Dir Assoc. 2020 Aug;21(8):1015-1023.e8. doi: 10.1016/j.jamda.2020.01.108. Epub 2020 Mar 27.
8
Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial.小长方形片剂在婴儿和幼儿中与糖浆和迷你片剂相比的可接受性:一项随机对照试验。
Eur J Pharm Biopharm. 2021 Sep;166:126-134. doi: 10.1016/j.ejpb.2021.06.007. Epub 2021 Jun 19.
9
Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: a systematic literature review.口服儿科药物的药剂学方面对患者相关结局的影响:系统文献回顾。
Clin Ther. 2010 May;32(5):924-38. doi: 10.1016/j.clinthera.2010.05.005.
10
Acceptability of an orodispersible film compared to syrup in neonates and infants: A randomized controlled trial.分散片与糖浆在新生儿和婴儿中的可接受性比较:一项随机对照试验。
Eur J Pharm Biopharm. 2020 Jun;151:239-245. doi: 10.1016/j.ejpb.2020.03.018. Epub 2020 Apr 26.

引用本文的文献

1
Evaluating palatability in young children: a mini-review of relevant physiology and assessment techniques.评估幼儿的适口性:相关生理学及评估技术的小型综述
Front Pediatr. 2024 Feb 8;12:1350662. doi: 10.3389/fped.2024.1350662. eCollection 2024.
2
A Guide to Best Practice in Sensory Analysis of Pharmaceutical Formulations.药物制剂感官分析最佳实践指南。
Pharmaceutics. 2023 Sep 14;15(9):2319. doi: 10.3390/pharmaceutics15092319.
3
Development and content validation of the Pediatric Oral Medicines Acceptability Questionnaires (P-OMAQ): patient-reported and caregiver-reported outcome measures.
儿童口服药物可接受性问卷(P-OMAQ)的开发与内容验证:患者报告和照顾者报告的结局指标
J Patient Rep Outcomes. 2020 Oct 1;4(1):80. doi: 10.1186/s41687-020-00246-1.
4
A Novel Oral Syringe for Dosing and Administration of Multiparticulate Formulations: Acceptability Study in Preschool and School Children.一种用于多颗粒制剂给药的新型口服注射器:学龄前儿童和学龄儿童的可接受性研究。
Pharmaceutics. 2020 Aug 25;12(9):806. doi: 10.3390/pharmaceutics12090806.
5
Acceptability of placebo multiparticulate formulations in children and adults.安慰剂多颗粒制剂在儿童和成人中的可接受性。
Sci Rep. 2018 Jun 15;8(1):9210. doi: 10.1038/s41598-018-27446-6.
6
Current opinions and recommendations of paediatric healthcare professionals - The importance of tablets: Emerging orally disintegrating versus traditional tablets.儿科保健专业人员的当前观点和建议 - 片剂的重要性:新兴的口腔崩解片与传统片剂。
PLoS One. 2018 Feb 28;13(2):e0193292. doi: 10.1371/journal.pone.0193292. eCollection 2018.
7
Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy.铁螯合疗法患者及照料者报告结局指标的定性改进与发展
Health Qual Life Outcomes. 2017 Jun 23;15(1):129. doi: 10.1186/s12955-017-0702-0.